July 15, 2025Open Access

Unveiling the Hidden Beat: Heart Rate Variability and the Vagus Nerve as Emerging Biomarkers in Breast Cancer Management

View Full Paper

Ask AI

Bookmark

Authors

CKConstantinos KoutsojannisUniversity of Patras DCDionysia ChrysanthakopoulouUniversity of Patras AFAthanasios FourasUniversity of Patras

Discussion

Member takes

Implication

Systematic review evaluates heart rate variability as a biomarker in breast cancer, highlighting the vagus nerve's role in inflammation and prognosis.

Key Points

Lower heart rate variability metrics are linked to advanced breast cancer stages and worse prognosis.
Chemotherapy significantly reduces heart rate variability, predicting potential cardiotoxicity.
Vagus nerve stimulation may enhance heart rate variability and decrease inflammation in breast cancer patients.
The findings suggest heart rate variability and vagal stimulation could transform breast cancer management and necessitate further research.

Cite This Study

Koutsojannis et al. (2025) studied this question.

synapsesocial.com/papers/689a02b6e6551bb0af8cc4e6 https://doi.org/10.20944/preprints202507.1156.v1

View Full Paper

Ask AI

Bookmark

Implication

Systematic review evaluates heart rate variability as a biomarker in breast cancer, highlighting the vagus nerve's role in inflammation and prognosis.

Unveiling the Hidden Beat: Heart Rate Variability and the Vagus Nerve as Emerging Biomarkers in Breast Cancer Management

Discussion

Member takes

Implication

Key Points

Cite This Study

Unveiling the Hidden Beat: Heart Rate Variability and the Vagus Nerve as Emerging Biomarkers in Breast Cancer Management

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider